Hair Multiplication: Can Scientists Multiply Your Hair Follicles?

Hair multiplication—the idea of making new hair follicles in a laboratory and using them to restore hair—is not currently an available treatment. Researchers are studying cells and signals that may help follicles grow, but there is no established procedure that creates new lab-grown follicles for transplantation. Today’s FUE and FUT surgeries redistribute follicles a patient already has, rather than multiplying them (ISHRS patient guide; FDA information on regenerative medicine therapies).

What “hair multiplication” means

The phrase can refer to several different ideas, so it is worth asking what a provider means by it. In research, scientists may study transplanting cells or tiny tissue samples, using substances released by cells, or using extracellular vesicles such as exosomes. These approaches are not the same as growing complete, new follicles in a laboratory and transplanting them.

That distinction matters when assessing claims. A procedure involving a patient’s cells or a regenerative product may be marketed with language such as “cell therapy” or “hair cloning,” but that does not mean it has created additional functional follicles. No stem-cell or regenerative product is FDA-approved for hair loss, and there is no clinically available hair-cloning procedure (FDA patient information; review of follicle regeneration).

What research has achieved so far

Research is exploring how cells and their signaling environments might support hair growth. In pattern hair loss, follicles can miniaturize, while some follicle stem cells remain present; researchers are investigating whether changing signals around the follicle could help restore activity. This is different from proving that a treatment can build a new follicle that grows, cycles, and behaves like a natural one (review of stem-cell approaches to hair loss).

A 2023 systematic review covered 15 studies and 653 participants who received a range of cell-based approaches, including follicle-derived micrografts and cells from adipose tissue. The studies reported increased hair density, but the authors noted limitations including small samples, different treatment protocols, and short follow-up. These findings are a reason for continued research, not proof that a standardized hair-multiplication treatment is ready for routine care (systematic review in Cells).

A 2026 systematic review also summarized clinical studies of several regenerative approaches. Its scope reflects active investigation, but the treatments studied were varied and do not establish that scientists can reliably manufacture transplantable follicles. Laboratory-grown follicles would need to develop and cycle, connect with surrounding tissue, receive a blood supply, and produce pigment. Solving those challenges is part of why a dependable clinical procedure remains unavailable (2026 systematic review; follicle regeneration review).

What patients can access—and how to assess claims

Hair transplantation remains a redistribution procedure: a surgeon moves follicles from one area of the scalp to another. That can be an option for some people, but it does not increase the total number of follicles available. A Hair Transplant Clinic can explain whether a person’s donor area, pattern of hair loss, and goals make surgery a reasonable consideration; individual suitability requires a professional assessment.

Some clinics also offer platelet-rich plasma or other regenerative treatments. These should not be confused with follicle multiplication. Evidence for PRP, for example, is distinct from evidence for PRF and does not show that new follicles have been created. When you visit a Hair Transplant Clinic, ask what cells or material are used, what the treatment is intended to do, what evidence supports that specific protocol, and whether it is part of a clinical study. Many Hair Transplant Clinics may use similar-sounding terms differently, so request a plain-language description of what is actually performed.

Be especially careful with claims about exosomes. The American Hair Loss Association states that exosome products are not FDA-approved for hair loss, that human evidence remains preliminary, and that protocols are not standardized. It also cautions that facility registration or an investigational new drug application does not equal FDA approval (exosome status overview).

An honest timeline for hair multiplication

There is no reliable date for when hair multiplication might become a patient-ready treatment. Research progress can show that a biological approach is worth studying without showing that it is safe, repeatable, effective over time, or available outside a research setting. Developing a complete follicle is a more complex goal than stimulating existing follicles or transferring cells and cell-derived products.

For now, treat definite launch dates, guaranteed outcomes, or claims of “unlimited donor hair” as reasons to ask for details rather than as established facts. Ask whether the procedure creates new follicles or uses existing ones, whether evidence comes from human studies of the same treatment, and whether results and risks have been independently evaluated. A transparent provider should be able to explain what is known, what is uncertain, and what alternatives are available without presenting experimental work as a proven cure.

Frequently Asked Questions

Is hair multiplication available now?

No established procedure currently creates new lab-grown follicles and transplants them for hair loss. Current hair transplant surgery moves a patient’s existing follicles, while cell-based approaches remain under investigation (ISHRS patient guide).

Do stem-cell or exosome treatments multiply follicles?

They have not been shown to provide clinically available hair multiplication. Some cell-based treatments are being studied for hair loss, but exosome products are not FDA-approved for hair loss and the evidence and protocols are not standardized (American Hair Loss Association overview).

When might hair cloning become a treatment?

No dependable timeline can be given. Researchers still need to solve challenges involved in producing follicles that function and cycle like natural ones, and early research does not establish when—or whether—a routine treatment will become available (follicle regeneration review).

Hair multiplication remains a scientific goal, not a treatment patients can count on today. If you are considering hair restoration, discuss established options and experimental claims with a qualified clinician, and ask for clear evidence about the specific procedure being offered.